Dudediligence.

Myriad Genetics, Inc

MYGNNASDAQ · In Vitro & in Vivo Diagnostic Substances
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Sep 168-KOfficer or director change and Regulation FD disclosure5.027.019.01
  2. Sep 413GPassive stake of 5% or more (13G), filed by BlackRock Portfolio Management
  3. Aug 1413GPassive stake of 5% or more (13G), filed by Vestal Point Capital
  4. Aug 713GPassive stake of 5% or more (13G)
  5. Jul 3110-QQuarterly report
  6. Jul 308-KResults of operations2.029.01
  7. Jun 238-KOfficer or director change5.02
  8. Jun 48-KOfficer or director change and shareholder vote5.025.079.01
  9. May 610-QQuarterly report
  10. May 58-KResults of operations2.029.01
  11. Mar 4424B3Prospectus for an offering
  12. Feb 24S-3Shelf registration
  13. Feb 2410-KAnnual report
  14. Feb 238-KResults of operations2.029.01
  15. Jan 128-KResults of operations2.029.01
  16. Nov 4, 202510-QQuarterly report
  17. Nov 4, 20258-K/AResults of operations (amended)2.029.01
  18. Nov 3, 20258-KResults of operations2.029.01
  19. Oct 7, 20258-KOfficer or director change5.029.01
  20. Oct 3, 20258-KOfficer or director change5.02
  21. Aug 18, 20258-KOfficer or director change5.029.01
  22. Aug 6, 202510-QQuarterly report
  23. Aug 5, 20258-KResults of operations2.029.01
  24. Jul 31, 20258-KMaterial agreement and other events1.012.038.019.01
  25. Jun 5, 20258-KOfficer or director change and shareholder vote5.025.079.01
  26. May 7, 202510-QQuarterly report
  27. May 6, 20258-KResults of operations2.029.01
  28. Feb 28, 202510-KAnnual report
  29. Feb 24, 20258-KResults of operations and officer or director change2.025.027.019.01
  30. Jan 15, 20258-KResults of operations2.029.01
  31. Dec 10, 20248-KOfficer or director change5.029.01
  32. Nov 26, 20248-KRegulation FD disclosure7.019.01
  33. Nov 8, 202410-QQuarterly report
  34. Nov 7, 20248-KResults of operations2.029.01
  35. Oct 9, 20248-KResults of operations2.029.01